Active ingredient
Metolazone
62 finished FDA listings contain Metolazone as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- METOLAZONE
- Dosage forms
- Tablet
- Routes
- Oral
- Manufacturers / labelers
- 19
- Strengths listed
- 10 mg/1 · 2.5 mg/1 · 5 mg/1
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 6916
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| ANDA 076466 | SANDOZ | 2003-12-19 | 6 |
| ANDA 076732 | SANDOZ | 2003-12-19 | 4 |
| ANDA 076698 | MYLAN | 2003-12-23 | 9 |
| ANDA 213251 | ALEMBIC | 2020-12-02 | 6 |
| ANDA 214799 | UNICHEM | 2021-03-30 | 3 |
| ANDA 213827 | INNOGENIX | 2021-03-30 | 19 |
| ANDA 215184 | RUBICON RESEARCH | 2021-08-20 | 4 |
| ANDA 215616 | RENATA | 2022-10-24 | 5 |
| ANDA 216216 | NE RX PHARMA | 2022-10-25 | 6 |
Official labeling on DailyMed
- METOLAZONE TABLET [SAFECOR HEALTH LLC] · version 3 · 2026-08-13
- METOLAZONE TABLET [BRYANT RANCH PREPACK] · version 102 · 2026-07-24
- METOLAZONE TABLET [BRYANT RANCH PREPACK] · version 102 · 2026-07-24
- METOLAZONE TABLET [BRYANT RANCH PREPACK] · version 102 · 2026-07-24
- METOLAZONE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.] · version 5 · 2026-06-30
- METOLAZONE TABLET [AMICI PHARMA, INC] · version 4 · 2026-04-02
- METOLAZONE TABLET [METHOD PHARMACEUTICALS, LLC] · version 5 · 2026-02-24
- METOLAZONE TABLET [ADVAGEN PHARMA LIMITED] · version 3 · 2026-01-16
- METOLAZONE TABLET [UNICHEM PHARMACEUTICALS (USA), INC.] · version 5 · 2025-12-12
- METOLAZONE TABLET [AARKISH PHARMACEUTICALS NJ INC.] · version 5 · 2025-12-10
- METOLAZONE TABLET [MAJOR PHARMACEUTICALS] · version 1 · 2025-11-25
- METOLAZONE TABLET [SANDOZ INC] · version 20 · 2025-11-25
Showing the 12 most recent of 30 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.